Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omicron-containing COVID-19 vaccine (Catholic Kwandong University)
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Omicron-containing COVID-19 vaccine (Catholic Kwandong University) refers to the specific Omicron-variant-targeting COVID-19 vaccine used as an intervention in a Phase 4 clinical trial (NCT06081374) conducted by Catholic Kwandong University. This vaccine is the formulation approved for the 2023-2024 season, which typically consists of monovalent mRNA or protein subunit vaccines targeting the SARS-CoV-2 XBB.1.5 subvariant. The study evaluates the immunogenicity and safety of this booster, particularly when co-administered with a quadrivalent influenza vaccine, by analyzing B-cell and T-cell responses in healthy adults.
- Other names
- Omicron-containing COVID-19 vaccineOmicron-containing COVID-19 booster
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on Omicron-containing COVID-19 vaccine (Catholic Kwandong University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omicron-containing COVID-19 vaccine (Catholic Kwandong University).